Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 17.828% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] Cc1cccnc1NC(=O)Nc1cccs1
[b] Cc1cc(SCC(=O)NCCC2=CCCCC2)nc2c(C)cccc12
[c] O=C(CN1CCN(c2nc(-c3ccc(F)cc3)cs2)CC1)Nc1ccc2c(c1)OCO2
Answer: b. Cc1cc(SCC(=O)NCCC2=CCCCC2)nc2c(C)cccc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(SCC(=O)NCCC2=CCCCC2)nc2c(C)cccc12
Cc1cc(SCC(=O)NCCC2=CCCCC2)nc2c(C)cccc12
N-[2-(cyclohexen-1-yl)ethyl]-2-(4,8-dimethylquinolin-2-yl)sulfanylacetamide